Litcius/Paper detail

Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?

Carlota Gudiol, Russell E. Lewis, Paolo Strati, Dimitrios P. Kontoyiannis

2021The Lancet Haematology69 citationsDOI

Topics & Concepts

Chimeric antigen receptorCytokine release syndromeImmunologyMedicineCytopeniaLymphomaAntigenImmunotherapyT cellCell therapyImmune systemCellBiologyBone marrowGeneticsCAR-T cell therapy researchVirus-based gene therapy research
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? | Litcius